Providing Emotional Support During the Process of Multiple Sclerosis Diagnosis (PrEliMS): A Feasibility Randomised Controlled Trial

被引:0
|
作者
das Nair, Roshan [1 ,2 ,3 ]
Mhizha-Murira, Jacqueline R. [1 ]
Topcu, Gogem [1 ]
Tindall, Tierney [1 ]
Bale, Clare [4 ]
Moghaddam, Nima [1 ,5 ]
Scheffler-Ansari, Grit [1 ]
Drummond, Avril [6 ]
Fitzsimmons, Deborah [7 ]
Evangelou, Nikos [1 ]
机构
[1] Univ Nottingham, Sch Med, Nottingham, England
[2] Nottinghamshire Healthcare NHS Fdn Trust, Inst Mental Hlth, Nottingham, England
[3] SINTEF, Hlth Div, Trondheim, Norway
[4] Multiple Sclerosis Patient & Publ Involvement Grp, Nottingham, England
[5] Univ Lincoln, Sch Psychol, Lincoln, England
[6] Univ Nottingham, Sch Hlth Sci, Nottingham, England
[7] Swansea Univ, Swansea Ctr Hlth Econ, Swansea, Wales
关键词
Multiple sclerosis; diagnosis; emotional support; psychological adjustment; peer support; QUALITY-OF-LIFE; PEOPLE; REHABILITATION;
D O I
10.1177/02692155241284781
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objectives To evaluate the feasibility and acceptability of an emotional support programme for newly diagnosed people with multiple sclerosis.Design Three-arm, mixed methods, randomised controlled trial comparing usual care, versus usual care plus nurse-specialist support, versus usual care plus nurse-specialist support plus peer support.Participants Community-dwelling adults within two years of diagnosis or undergoing diagnosis.Interventions PrEliMS involves information provision, emotional support, and strategies and techniques based on psychoeducation, Acceptance and Commitment Therapy principles, supportive listening. One version of the intervention was provided by nurse-specialists alone and the other was provided by nurse-specialists plus peer support.Main measures The main outcome of interest was the feasibility of proceeding to a definitive trial, exploring recruitment rate, acceptability, completion of outcome measures (perceived stress, mood, self-efficacy, psychological impact, and service use), and signal of efficacy.Results Of 40 participants randomised (mean age 36.2 years (SD = 14.8); 54% women; 85% with relapsing-remitting MS), 36 and 38 returned 3- and 6-month questionnaires, respectively. Participant interviews suggested the trial was largely feasible, and the intervention acceptable, with some amendments to trial procedures and intervention delivery noted. There were, however, no statistically significant differences between groups at followup for any measures, and effect-size estimates were small.Conclusion A definitive trial combining nurse-specialist and peer support adjustment to diagnosis intervention is warranted, but more work exploring the delivery and fidelity of the intervention is needed before this is pursued
引用
收藏
页码:1506 / 1520
页数:15
相关论文
共 50 条
  • [1] Providing emotional support around the point of multiple sclerosis diagnosis (PrEliMS): A feasibility randomised controlled trial
    Das Nair, Roshan
    Mhizha-Murira, Jacqueline R.
    Topcu, Gogem
    Tindal, Tierney
    Bale, Clare
    Moghaddam, Nima
    Scheffler-Ansari, Grit
    Drummond, Avril
    Fitzsimmons, Deborah
    Evangelou, Nikos
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 66 - 66
  • [2] Training physicians in providing complex information to patients with multiple sclerosis: a randomised controlled trial
    Nordfalk, Jenny M.
    Holmoy, Trygve
    Thomas, Owen
    Nylenna, Magne
    Gulbrandsen, Pal
    BMJ OPEN, 2022, 12 (03):
  • [3] Balance Right in Multiple Sclerosis (BRiMS): preliminary results of a randomised controlled feasibility trial
    Freeman, J.
    Gunn, H.
    Andrade, J.
    Paul, L.
    Miller, L.
    Stevens, K.
    Green, C.
    Ewings, P.
    Barton, A.
    Berrow, M.
    Vickery, J.
    Marshall, B.
    Marsden, J.
    Creanor, S.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 726 - 726
  • [4] A randomised controlled trial to test the feasibility of online mindfulness programs for people with multiple sclerosis
    Dunne, Jennifer
    Chih, Hui Jun
    Begley, Andrea
    Daly, Alison
    Gerlach, Regina
    Schutze, Robert
    Castell, Emily
    Byrne, Jean
    Black, Lucinda J.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 48
  • [5] Balance Right in Multiple Sclerosis (BRiMS): Preliminary results of a randomised controlled feasibility trial
    Gunn, Hilary
    Andrade, J.
    Paul, L.
    Miller, L.
    Creanor, S.
    Stevens, K.
    Green, C.
    Ewings, P.
    Barton, A.
    Berrow, M.
    Vickery, J.
    Marshall, B.
    Marsden, J.
    Freeman, J. A.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (06) : 870 - 870
  • [6] Acceptance-based telephone support around the time of transition to secondary progressive multiple sclerosis: A feasibility randomised controlled trial
    Meek, Christopher
    Moghaddam, Nima G.
    Evangelou, Nikos
    Oates, Lloyd L.
    Topcu, Gogem
    Allen, Christopher
    das Nair, Roshan
    JOURNAL OF CONTEXTUAL BEHAVIORAL SCIENCE, 2021, 21 : 158 - 170
  • [7] Balance Right in Multiple Sclerosis (BRiMS): a feasibility randomised controlled trial of a falls prevention programme
    H. Gunn
    K. N. Stevens
    S. Creanor
    J. Andrade
    L. Paul
    L. Miller
    C. Green
    P. Ewings
    A. Barton
    M. Berrow
    J. Vickery
    B. Marshall
    J. Zajicek
    J. A. Freeman
    Pilot and Feasibility Studies, 7
  • [8] Mindfulness-based stress reduction for people with multiple sclerosis - a feasibility randomised controlled trial
    Simpson, Robert
    Mair, Frances S.
    Mercer, Stewart W.
    BMC NEUROLOGY, 2017, 17
  • [9] Balance Right in Multiple Sclerosis (BRiMS): a feasibility randomised controlled trial of a falls prevention programme
    Gunn, H.
    Stevens, K. N.
    Creanor, S.
    Andrade, J.
    Paul, L.
    Miller, L.
    Green, C.
    Ewings, P.
    Barton, A.
    Berrow, M.
    Vickery, J.
    Marshall, B.
    Zajicek, J.
    Freeman, J. A.
    PILOT AND FEASIBILITY STUDIES, 2021, 7 (01)
  • [10] Mindfulness-based stress reduction for people with multiple sclerosis – a feasibility randomised controlled trial
    Robert Simpson
    Frances S. Mair
    Stewart W. Mercer
    BMC Neurology, 17